English
往期目录
新闻公告
More
化学进展 2018, Vol. 30 Issue (10): 1557-1572 DOI: 10.7536/PC180612 前一篇   后一篇

• 综述 •

铂类抗癌药物的多功能纳米递送体系

沈娟1,2*, 朱阳2, 师红东2, 刘扬中2*   

  1. 1. 安徽医科大学公共卫生学院 合肥 230032;
    2. 中国科学技术大学化学系 合肥 230026
  • 收稿日期:2018-06-11 修回日期:2018-07-27 出版日期:2018-10-15 发布日期:2018-09-25
  • 通讯作者: 沈娟, 刘扬中 E-mail:liuyz@ustc.edu.cn;shenjuan@ahmu.edu.cn
  • 基金资助:
    国家重大科学研究计划项目（No.2012CB932502）、江苏省自然科学基金项目（No.BK20151238）和苏州市科技计划项目（No.SYG201624）资助
下载PDF ( 1019 ) 引用
导出

Multifunctional Nanodrug Delivery Systems for Platinum-Based Anticancer Drugs

Juan Shen1,2*, Yang Zhu2, Hongdong Shi2, Yangzhong Liu2*   

  1. 1. School of Public Health, Anhui Medical University, Hefei 230032;
    2. Department of Chemistry, University of Science and Technology of China, Hefei 230026, China
  • Received:2018-06-11 Revised:2018-07-27 Online:2018-10-15 Published:2018-09-25
  • Supported by:
    The work was supported by the National Basic Research Program of China(No. 2012CB932502), the Jiangsu Natural Science Foundation(No. BK20151238), and the Suzhou Science and Technology Projects(No. SYG201624).
以顺铂为代表的小分子铂类抗癌药物是临床应用的一线化疗药物，但其严重的毒副作用和难以克服的耐药性限制了铂类药物的临床应用和研发。运用纳米药物递送技术可以实现药物的靶向递送和可控释放，来提高药物的生物利用度，降低药物的毒副作用以及耐药性，为癌症的治疗带来新的希望。此外，丰富多样的纳米递送体系易于实现药物与具有生物学活性试剂的共运输，从而为各种治疗策略以及诊疗策略的联用提供可能，为最终实现癌症的精准治疗展现广阔前景。本文从靶向递药、药物可控释放、联合治疗、诊疗一体化四个方面对铂类抗癌药物的多功能纳米递送体系在癌症治疗中的最新研究进展进行综述，同时通过列举最新研究成果，展示了新材料、新技术以及新颖设计思想在铂基纳米递送体系中的应用。
关键词： 铂, 抗癌药物, 纳米载药体系, 靶向递药, 可控释放, 联合治疗, 诊疗一体化
Platinum-based chemotherapy, especially cisplatin, is the standard first-line treatment for various types of cancer. However, the clinical application and development of platinum drugs have been greatly hampered by their severe adverse effects and inescapable drug resistance. The use of nanodrug delivery technology can effectively achieve targeted and controlled drug delivery and release. Moreover, nanodrug delivery technology can increase the bioavailability of platinum agents, reduce system toxicity and overcome the drug resistance. Therefore, it shows great potential for the treatment of cancer. In addition, the versatile nanocarriers facilitate the co-delivery of multiple agents with different bioactive functions, thereby providing possibilities for the combination therapy or theranostics in a single platform. Hence, nanodrug delivery systems present broad prospects for the precise cancer treatment. This article reviews the recent progress in the applications of multifunctional platinum-based nanodrug delivery systems for cancer therapy, and it consists of four aspects:targeted drug delivery, controlled drug release, combination therapy and theranostics. Meanwhile, the applications of new materials, new technologies and novel design ideas in platinum-based nanodrug delivery systems are also presented.
Contents
1 Introduction
2 Targeted drug delivery
2.1 Passive targeting based on EPR effect
2.2 Active targeting
3 Controlled drug release
3.1 pH-sensitive systems
3.2 Reduction-sensitive systems
3.3 Thermo-sensitive systems
3.4 Enzyme-sensitive systems
4 Combination therapy
4.1 Co-delivery of chemotherapeutic agents
4.2 Co-delivery of gene drugs and platinum agents
4.3 Co-delivery of phototherapy reagents and platinum agents
5 Theranostics
5.1 MRI-based theranostics
5.2 Optical imaging-based theranostics
5.3 Multimodal bioimaging-based theranostics
6 Conclusion and outlook
Key words: platinum, anticancer drug, nanodrug delivery systems, targeted drug delivery, controlled release, combination therapy, theranostics

中图分类号: 

()
[1] Rosenberg B, Vancamp L, Krigas T. Nature, 1965, 205:698.
[2] 郑小辉(Zheng X H), 夏立新(Xia L X), 毛宗万(Mao Z W). 化学进展(Progress in Chemistry), 2016, 28(7):1029.
[3] Johnstone T C, Suntharalingam K, Lippard S J. Chem. Rev., 2016, 116:3436.
[4] Ali I, Wani W A, Saleem K, Haque A. Anticancer Agents Med. Chem., 2013, 13:296.
[5] Shen D W, Pouliot L M; Hall M D, Gottesman M M. Pharmacol. Rev., 2012, 64:706.
[6] Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G. Cell Death Dis., 2014, 5:e1257.
[7] 王晓勇(Wang X Y), 郭子建(Guo Z J). 化学进展(Progress in Chemistry), 2009, 21(5):845.
[8] Cheng Q Q, Liu Y Z. WIRE Nanomed. Nanobiotechnol., 2017, 9:e1410.
[9] Apps M G, Choi E H, Wheate N J. Endocr.Relat. Cancer, 2015, 22:R219.
[10] Ma Y F, Huang J, Song S J, Chen H B, Zhang Z J. Small, 2016, 12:4936.
[11] Murakami M, Cabral H, Matsumoto Y, Wu S R, Kano M R, Yamori T, Nishiyama N, Kataoka K. Sci. Transl. Med., 2011, 3:64ra2.
[12] Wang E Q, Xi Z Y, Li Y, Li L Z, Zhao L H, Ma G L, Liu Y Z. Inorg. Chem., 2013, 52:6153.
[13] Fang T T, Tian Y, Yuan S M, Sheng Y P, Fabio A, Natile G, Liu Y Z. Chem. Eur. J., 2018, 24:1.
[14] 房田田(Fang T T), 曹开明(Cao K M), 程岚军(Cheng L J), 赵林泓(Zhao L H), 刘扬中(Liu Y Z). 中国科学:化学(Scientia Sinica Chimica), 2017, 47(2):200.
[15] Zasadzinski J A, Wong B, Forbes N, Braun G, Wu G H. Curr. Opin. Coll. Int. Sci., 2011, 16:203.
[16] Maeda H, Ueda M, Morinaga T, Matsumoto T. J. Med. Chem., 1985, 28:455.
[17] Alexis F, Pridgen E, Molnar L K, Farokhzad O C. Mol. Pharm., 2008, 5:505.
[18] Daglar B, Ozgur E, Corman M E, Uzun L, Demirel G B. RSC Adv., 2014, 4:48639.
[19] Owens D E, Peppas N A. Int. J. Pharm., 2006, 307:93.
[20] Ou H, Cheng T, Zhang Y, Liu J, Ding Y, Zhen J, Shen W, Xu Y, Yang W, Niu P. Acta Biomater., 2018, 65:339.
[21] David A. Adv. Drug Deliver. Rev, 2017, 119:120.
[22] Ishida T, Kiwada H. Int. J. Pharm., 2008, 354:56.
[23] Kontos S, Hubbell J A. Chem. Soc. Rev., 2012, 41:2686.
[24] Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano M R, Miyazono K, Uesaka M, Nishiyama N, Kataoka K. Nat. Nanotechnol., 2011, 6:815.
[25] Wang Y F, Zhou J H, Qiu L H, Wang X R, Chen L L, Liu T, Di W. Biomaterials, 2014, 35:4297.
[26] Peng X H, Wang Y Q, Huang D H, Wang Y X, Shin H J, Chen Z J, Spewak M B, Mao H, Wang X, Wang Y, Chen Z, Nie S M, Shin D M. ACS Nano, 2011, 5:9480.
[27] Sara Z, Contreras A M, Azadeh H, Hagen T L M, Ten, Iñigo N, Gerben K, Garrido M J. J. Control. Release, 2015, 210:26.
[28] Lin C Y, Yang S J, Peng C L, Shieh M J. ACS Appl. Mater. Interfaces, 2018, 10:6096.
[29] Liu J K. Ann. Med. Surg., 2014, 3:113.
[30] Chen Y, Liu G H, Guo L F, Wang H, Fu Y, Luo Y Z. Int. J. Cancer, 2015, 136:182.
[31] Tai W Y, Mahato R, Cheng K. J. Control. Release, 2010, 146:264.
[32] Kesavan A, Ilaiyaraja P, Beaula W S, Kumari V V, Lal J S, Arunkumar C, Anjana G, Srinivas S, Ramesh A, Rayala S K. Eur. J. Pharm. Biopharm., 2015, 96:255.
[33] Mi Y, Zhao J, Feng S S. J. Control. Release, 2013, 169:185.
[34] Huang R, Sun Y, Zhang X Y, Sun B W, Wang Q C, Zhu J. Biomed. Pharmacother., 2015, 73:116.
[35] Huang R, Wang Q C, Zhang X Y, Zhu J, Sun B W. Biomed. Pharmacother., 2015, 72:17.
[36] Huang R, Sun Y, Gao Q H, Wang Q C, Sun B W. Anti-Cancer Drug, 2015, 26:957.
[37] Vinogradov S, Wei X. Nanomedicine, 2012, 7:597.
[38] Liu H, Lv L, Yang K. Am. J.Cancer Res., 2015, 5:880.
[39] Yu W K, Wang Z G, Fong C C, Liu D D, Yip T C, Au S K, Zhu G Y, Yang M S. Brit. J. Pharmacol., 2017, 174:302.
[40] Thapa R, Wilson G D. Stem Cells Int., 2016, 2016:2087204.
[41] Bai M Y, Liu S Z. Colloids Surf. B Biointerfaces, 2014, 117:346.
[42] Desgrosellier J S, Cheresh D A. Nat. Rev. Cancer, 2010, 10:890.
[43] Zhao G, Rodriguez B L. Int. J. Nanomedicine, 2013, 8:61.
[44] Graf N, Bielenberg D R, Kolishetti N, Muus C, Banyard J, Farokhzad O C, Lippard S J. ACS Nano, 2012, 6:4530.
[45] Miura Y, Takenaka T, Toh K, Wu S, Nishihara H, Kano M R, Ino Y, Nomoto T, Matsumoto Y, Koyama H. ACS Nano, 2013, 7:8583.
[46] Babu A, Amreddy N, Muralidharan R, Pathuri G, Gali H, Chen A, Zhao Y D, Munshi A, Ramesh R. Sci. Rep., 2017, 7:14674.
[47] Nagy A, Schally A V. Biol. Reprod., 2005, 73:851.
[48] Nukolova N V, Oberoi H S, Zhao Y, Chekhonin V P, Kabanov A V, Bronich T K. Mol. Pharm., 2013, 10:3913.
[49] Li M Q, Tang Z H, Zhang Y, Lv S X, Li Q S, Chen X S. Acta Biomater., 2015, 18:132.
[50] Li M Q, Tang Z H, Zhang Y, Lv S X, Yu H Y, Zhang D W, Hong H, Chen X S. J. Mater. Chem. B, 2014, 2:3490.
[51] Li X, Zhao Q H, Qiu L Y. J. Control. Release, 2013, 171:152.
[52] Dhar S, Gu F X, Langer R, Farokhzad O C, Lippard S J. Proc. Natl. Acad. Sci. U. S. A., 2008, 105:17356.
[53] Dhar S, Kolishetti N, Lippard S J, Farokhzad O C. Proc. Natl. Acad. Sci. U. S. A., 2011, 186:1850.
[54] Sudimack J, Lee R J. Adv. Drug Delivery Rev., 2000, 41:147.
[55] Dhar S, Liu Z, Thomale J, Dai H J, Lippard S J. J. Am. Chem. Soc., 2008, 130:11467.
[56] Nukolova N V, Oberoi H S, Cohen S M, Kabanov A V, Bronich T K. Biomaterials, 2011, 32:5417.
[57] Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrotta I, Panno M L, Tagarelli A, Versace C, Casula M F, Testa F, Ando S, Nagy J B, Pasqua L. Nanoscale, 2011, 3:3198.
[58] Shirbin S J, Ladewig K, Fu Q, Klimak M, Zhang X Q, Duan W, Qiao G G. Biomacromolecules, 2015, 16:2463.
[59] Ren W X, Han J Y, Uhm S, Jang Y J, Kang C, Kim J H, Kim J S. Chem. Commun., 2015, 51:10403.
[60] Cao L P, Hettiarachchi G, Briken V, Isaacs L. Angew.Chem.Int.Ed., 2013, 52:12033.
[61] Liu J, Huang Y R, Kumar A, Tan A, Jin S B, Mozhi A, Liang X J. Biotechnol. Adv., 2014, 32:693.
[62] Fukumura D, Jain R K. J. Cell. Biochem., 2007, 101:937.
[63] Lee E S, Gao Z G, Bae Y H. J. Control. Release, 2008, 132:164.
[64] Lee E S, Oh K T, Kim D, Youn Y S, Bae Y H. J. Control. Release, 2007, 123:19.
[65] Huang Y, Tang Z H, Zhang X F, Yu H Y, Sun H, Pang X, Chen X S. Biomacromolecules, 2013, 14:2023.
[66] Xu P S, Van Kirk E A, Murdoch W J, Zhan Y H, Isaak D D, Radosz M, Shen Y Q. Biomacromolecules, 2006, 7:829.
[67] Aryal S, Hu C M J, Zhang L F. ACS Nano, 2010, 4:251.
[68] Cheng K, Peng S, Xu C J, Sun S H. J. Am. Chem. Soc., 2009, 131:10637.
[69] Shi H D, Cheng Q Q, Yuan S M, Ding X, Liu Y Z. Chem. Eur. J., 2015, 21:16547.
[70] Pan D Y, She W C, Guo C H, Luo K, Yi Q Y, Gu Z W. Biomaterials, 2014, 35:10080.
[71] Navrotsky A. Proc. Natl. Acad. Sci. U.S.A., 2004, 101:12096.
[72] Vonarbourg A, Passirani C, Saulnier P, Benoit J P. Biomaterials, 2006, 27:4356.
[73] Ma D. Nanoscale, 2014, 6:6415.
[74] Zeng B R, Shi H D, Liu Y Z. J. Mater. Chem. B, 2015, 3:9115.
[75] Yang X Z, Du X J, Liu Y, Zhu Y H, Liu Y Z, Li Y P, Wang J. Adv. Mater., 2014, 26:931.
[76] Mura S, Nicolas J, Couvreur P. Nat. Mater., 2013, 12:991.
[77] Wang Y, Shim M S, Levinson N S, Sung H W, Xia Y. Adv. Funct. Mater., 2014, 24:4206.
[78] Gamcsik M P, Kasibhatla M S, Teeter S D, Colvin O M. Biomarkers, 2012, 17:671.
[79] Shi Y, Liu S A, Kerwood D J, Goodisman J, Dabrowiak J C. J. Inorg. Biochem., 2012, 107:6.
[80] Min Y Z, Mao C Q, Xu D C, Wang J, Liu Y Z. Chem. Commun., 2010, 46:8424.
[81] Min Y Z, Mao C Q, Chen S M, Ma G L, Wang J, Liu Y Z. Angew.Chem.Int.Ed., 2012, 51:6742.
[82] Ma R, Wang Z G, Yan L, Chen X F, Zhu G Y. J. Mater. Chem. B, 2014, 2:4868.
[83] Cheng Q Q, Shi H D, Huang H, Cao Z T, Wang J, Liu Y Z. Chem. Commun., 2015, 51:17536.
[84] Zhang W, Li Y, Sun J H, Tan C P, Ji L N, Mao Z W. Chem. Commun., 2015, 51:1807.
[85] Muhammad N, Wang X Y, Wang K, Zhu C C, Zhu Z Z, Jiao Y, Guo Z J. Dalton Trans., 2016, 45:13169.
[86] Wang Z F, Liu H L, Shu X M, Zheng L, Chen L J. Colloids Surf. B Biointerfaces, 2015, 136:160.
[87] Kono K. Adv. Drug Delivery Rev., 2001, 53:307.
[88] Tagami T, Ernsting M J, Li S D. J. Control. Release, 2011, 152:303.
[89] Liu H, Zhang Y L, Han Y Z, Zhao S, Wang L, Zhang Z X, Wang J, Cheng J X. Colloids Surf. B Biointerfaces, 2015, 131:12.
[90] Chen J P, Cheng T H. Polymer, 2009, 50:107.
[91] Chen J P, Leu Y L, Fang C L, Chen C H, Fang J Y. J. Pharm. Sci., 2011, 100:655.
[92] Shirakura T, Kelson T J, Ray A, Malyarenko A E, Kopelman R. ACS Macro Lett., 2014, 3:602.
[93] Salimi F, Dilmaghani K A, Alizadeh E, Akbarzadeh A, Davaran S. Artif. Cell. Nanomed. Biotechnol., 2018, 46:949.
[94] Peng J R, Qi T T, Liao J F, Chu B Y, Yang Q, Li W T, Qu Y, Luo F, Qian Z Y. Biomaterials, 2013, 34:8726.
[95] Cheng R, Meng F H, Deng C, Zhong Z Y. Nano Today, 2015, 10:656.
[96] Kessenbrock K, Plaks V, Werb Z. Cell, 2010, 141:52.
[97] Kim J K, Anderson J, Jun H W, Repka M A, Jo S. Mol. Pharm., 2009, 6:978.
[98] van Rijt S H, Bolukbas D A, Argyo C, Datz S, Lindner M, Eickelberg O, Konigshoff M, Bein T, Meiners S. ACS Nano, 2015, 9:2377.
[99] Surnar B, Jayakannan M. ACS Biomater. Sci. Eng., 2016, 2:1926.
[100] Surnar B, Subash P P, Jayakannan M. Z. Anorg. Allg. Chem, 2014, 640:1119.
[101] Surnar B, Sharma K, Jayakannan M. Nanoscale, 2015, 7:17964.
[102] Chen J M, Dando P M, Rawlings N D, Brown M A, Young N E, Stevens R A, Hewitt E, Watts C, Barrett A J. J. Biol. Chem., 1997, 272:8090.
[103] Shi T Y, Gu L S, Sun Y, Wang S L, Zhang X Y, Zhu J, Sun B W. Eur. Polym. J., 2017, 92:105.
[104] Saraswathy M, Gong S Q. Mater. Today, 2014, 17:298.
[105] Qi S S, Sun J H, Yu H H, Yu S Q. Drug Deliv., 2017, 24:1909.
[106] Tolcher A W, Mayer L D. Future Oncol., 2018, 14:1317.
[107] Nitiss J L. Nat. Rev. Cancer, 2009, 9:338.
[108] Aliosman F, Berger M S, Rajagopal S, Spence A, Livingston R B. Cancer Res., 1993, 53:5663.
[109] Lee S M, O'Halloran T V, Nguyen S T. J. Am. Chem. Soc., 2010, 132:17130.
[110] Liao L Y, Liu J, Dreaden E C, Morton S W, Shopsowitz K E, Hammond P T, Johnson J A. J. Am. Chem. Soc., 2014, 136:5896.
[111] Shanmugam V, Chien Y H, Cheng Y S, Liu T Y, Huang C C, Su C H, Chen Y S, Kumar U, Hsu H F, Yeh C S. ACS Appl. Mater. Interfaces, 2014, 6:4382.
[112] Zhu C Y, Xiao J J, Tang M, Feng H, Chen W L, Du M. Int. J. Nanomedicine, 2017, 12:3697.
[113] Xiao H H, Li W L, Qi R G, Yan L S, Wang R, Liu S, Zheng Y H, Xie Z G, Huang Y B, Jing X B. J. Control. Release, 2012, 163:304.
[114] Poon C, He C, Liu D, Lu K, Lin W. J. Control. Release, 2015, 201:90.
[115] Miao L, Guo S, Zhang J, Kim W Y, Huang L. Adv. Funct. Mater., 2014, 24:6601.
[116] Qu C Y, Zhou M, Chen Y W, Chen M M, Shen F, Xu L M. Int. J. Nanomedicine, 2015, 10:3911.
[117] Ma H C, He C L, Cheng Y L, Yang Z M, Zang J T, Liu J G, Chen X S. ACS Appl. Mater. Interfaces, 2015, 7:27040.
[118] Toschi L, Finocchiaro G, Bartolini S, Gioia V, Cappuzzo F. Future Oncol., 2005, 1:7.
[119] Li A, Wei Z J, Ding H, Tang H S, Zhou H X, Yao X, Feng S Q. Oncotarget, 2017, 8:57365.
[120] Rhee E J, Jeong H S, Lee S S. Cancer Res. Treat., 2002, 34:28.
[121] Desale S S, Cohen S M, Zhao Y, Kabanov A V, Bronich T K. J.Control. Release, 2013, 171:339.
[122] Cai L Q, Xu G F, Shi C Y, Guo D D, Wang X, Luo J T. Biomaterials, 2015, 37:456.
[123] Fang Y, Zheng G F, Yang J P, Tang H S, Zhang Y F, Kong B, Lv Y Y, Xu C J, Asiri A M, Zi J, Zhang F, Zhao D Y. Angew.Chem.Int.Ed., 2014, 53:5366.
[124] He Z L, Huang J W, Xu Y Y, Zhang X Y, Teng Y W, Huang C, Wu Y F, Zhang X, Zhang H J, Sun W J. Oncotarget, 2015, 6:42150.
[125] Liu B, Han L, Liu J, Han S, Chen Z, Jiang L. Int. J. Nanomedicine, 2017, 12:955.
[126] Song W, Tang Z, Zhang D, Zhang Y, Yu H, Li M, Lv S, Sun H, Deng M, Chen X. Biomaterials, 2014, 35:3005.
[127] Chang C E, Hsieh C M, Chen L C, Su C Y, Liu D Z, Jhan H J, Ho H O, Sheu M T. Drug Deliv., 2018, 25:632.
[128] Xiao H H, Yan L S, Zhang Y, Qi R G, Li W L, Wang R, Liu S, Huang Y B, Li Y X, Jing X B. Chem. Commun., 2012, 48:10730.
[129] Guo S T, Lin C M, Xu Z H, Miao L, Wang Y H, Huang L. ACS Nano, 2014, 8:4996.
[130] Ma R, Wang Y P, Yan L, Ma L L, Wang Z G, Chan H C, Chiu S K, Chen X F, Zhu G Y. Chem. Commun., 2015, 51:7859.
[131] Amer M H. Mol. Cell. Ther., 2014, 2:27.
[132] Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Oncogene, 2012, 31:1869.
[133] Agrawal N, Dasaradhi P V, Mohmmed A, Malhotra P, Bhatnagar R K, Mukherjee S K. Microbiol. Mol. Biol. Rev., 2003, 67:657.
[134] Xie K, Doles J, Hemann M T, Walker G C. Proc. Natl. Acad. Sci. U. S. A., 2010, 107:20792.
[135] Doles J, Oliver T G, Cameron E R, Hsu G, Jacks T, Walker G C, Hemann M T. Proc. Natl. Acad. Sci. U.S.A., 2010, 107:20786.
[136] Xu X Y, Xie K, Zhang X Q, Pridgen E M, Park G Y, Cui D S, Shi J J, Wu J, Kantoff P W, Lippard S J, Langer R, Walker G C, Farokhzad O C. Proc. Natl. Acad. Sci. U. S. A., 2013, 110:18638.
[137] Shen S, Sun C Y, Du X J, Li H J, Liu Y, Xia J X, Zhu Y H, Wang J. Biomaterials, 2015, 70:71.
[138] Zheng W J, Cao C W, Liu Y N, Yu Q Q, Zheng C P, Sun D D, Ren X F, Liu J. Acta Biomater., 2015, 11:368.
[139] He C B, Lu K D, Liu D M, Lin W B. J. Am. Chem. Soc., 2014, 136:5181.
[140] Wong D Y Q, Yeo C H F, Ang W H. Angew. Chem. Int. Ed., 2014, 53:6752.
[141] Hernandez-Gil J, Cobaleda-Siles M, Zabaleta A, Salassa L, Calvo J, Mareque-Rivas J C. Adv. Healthc. Mater., 2015, 4:1034.
[142] Alsaab H O, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw S K, Iyer A K. Front. Pharmacol., 2017, 8:561.
[143] Mazarei G, Leavitt B R. J. Huntingtons Dis., 2015, 4:109.
[144] Prendergast G C. Oncogene, 2008, 27:3889.
[145] Wang N, Wang Z G, Xu Z F, Chen X F, Zhu G Y. Angew.Chem.Int.Ed., 2018, 57:3426.
[146] Gong H, Dong Z L, Liu Y M, Yin S N, Cheng L, Xi W Y, Xiang J, Liu K, Li Y G, Liu Z. Adv. Funct. Mater., 2014, 24:6492.
[147] Liu B, Li C X, Chen G Y, Liu B, Deng X R, Wei Y, Xia J, Xing B G, Ma P A, Lin J. Adv. Sci., 2017, 4:1600540.
[148] Li J W, Lyv Z L, Li Y L, Liu H, Wang J K, Zhan W J, Chen H, Chen H B, Li X M. Biomaterials, 2015, 51:12.
[149] You C Q, Wu H S, Wang M X, Gao Z G, Zhang X Y, Sun B W. Nanotechnology, 2018, 29:015601.
[150] He C B, Liu D M, Lin W B. ACS Nano, 2015, 9:991.
[151] Sawant R R, Jhaveri A M, Torchilin V P. Adv. Drug Deliver. Rev., 2012, 64:1436.
[152] Mura S, Couvreur P. Adv. Drug Delivery Rev., 2012, 64:1394.
[153] Liu Y J, Zhang N. Biomaterials, 2012, 33:5363.
[154] Vinh N Q, Naka S, Cabral H, Murayama H, Kaida S, Kataoka K, Morikawa S, Tani T. Int. J. Nanomedicine, 2015, 10:4137.
[155] Kaida S, Cabral H, Kumagai M, Kishimura A, Terada Y, Sekino M, Aoki I, Nishiyama N, Tani T, Kataoka K. Cancer Res., 2010, 70:7031.
[156] Ren L L, Chen S Z, Li H D, Zhang Z Y, Zhong J P, Liu M L, Zhou X. Acta Biomater., 2016, 35:260.
[157] Zhu Z Z, Wang Z H, Hao Y G, Zhu C C, Jiao Y, Chen H C, Wang Y M, Yan J, Guo Z J, Wang X Y. Chem. Sci., 2016, 7:2864.
[158] Cheng Z Y, Dai Y L, Kang X J, Li C X, Huang S S, Lian H Z, Hou Z Y, Ma P A, Lin J. Biomaterials, 2014, 35:6359.
[159] Mohapatra S, Rout S R, Narayan R, Maiti T K. Dalton Trans., 2014, 43:15841.
[160] Chen W H, Luo G F, Lei Q, Cao F Y, Fan J X, Qiu W X, Jia H Z, Hong S, Fang F, Zeng X, Zhuo R X, Zhang X Z. Biomaterials, 2016, 76:87.
[161] Lee P C, Lin C Y, Peng C L, Shieh M J. Biomater. Sci., 2016, 4:1742.
[162] Luker G D, Luker K E. J. Nucl. Med., 2008, 49:1.
[163] Mader H S, Kele P, Saleh S M, Wolfbeis O S. Curr. Opin. Chem. Biol, 2010, 14:582.
[164] Dai Y L, Xiao H H, Liu J H, Yuan Q H, Ma P A, Yang D M, Li C X, Cheng Z Y, Hou Z Y, Yang P P, Lin J. J. Am. Chem. Soc., 2013, 135:18920.
[165] Shi H D, Fang T T, Tian Y, Huang H, Liu Y Z. J. Mater. Chem. B, 2016, 4:4746.
[166] Wu T T, Huang H, Sheng Y P, Shi H D, Min Y Z, Liu Y Z. J. Mater. Chem. B, 2018, 6:1011.
[167] Wang F, Liu X G. J. Am. Chem. Soc., 2008, 130:5642.
[168] Dai Y L, Kang X J, Yang D M, Li X J, Zhang X, Li C X, Hou Z Y, Cheng Z Y, Ma P A, Lin J. Adv. Healthc. Mater., 2013, 2:514.
[169] Ma P A, Xiao H H, Li X X, Li C X, Dai Y L, Cheng Z Y, Jing X B, Lin J. Adv. Mater., 2013, 25:4898.
[170] Perfahl S, Natile M M, Mohamad H S, Helm C A, Schulzke C, Natile G, Bednarski P J. Mol. Pharm., 2016, 13:2346.
[171] Xia J, Yao J J, Wang L V. Prog. Electromagn. Res., 2014, 147:1.
[172] Xu M H, Wang L H V. Rev. Sci. Instrum., 2006, 77:041101.
[173] Hu S, Wang L V. J. Biomed. Opt., 2010, 15:011101.
[174] Stacy M R, Sinusas A J. Curr. Pathobiol. Rep., 2015, 3:27.
[175] Key J, Leary J F. Int. J. Nanomedicine, 2014, 9:711.
[1] 冯海弟, 赵璐, 白云峰, 冯锋. 纳米金属有机框架在肿瘤靶向治疗中的应用[J]. 化学进展, 2022, 34(8): 1863-1878.
[2] 钟琴, 周帅, 王翔美, 仲维, 丁晨迪, 傅佳骏. 介孔二氧化硅基智能递送体系的构建及其在各类疾病治疗中的应用[J]. 化学进展, 2022, 34(3): 696-716.
[3] 孟鹏飞, 张笑容, 廖世军, 邓怡杰. 金属/非金属元素掺杂提升原子级分散碳基催化剂的氧还原性能[J]. 化学进展, 2022, 34(10): 2190-2201.
[4] 徐云雪, 刘仁发, 徐坤, 戴志飞. 手术导航用荧光探针[J]. 化学进展, 2021, 33(1): 52-65.
[5] 赖欣宜, 王志勇, 郑永太, 陈永明. 纳米金属有机框架材料在药物递送领域的应用[J]. 化学进展, 2019, 31(6): 783-790.
[6] 李红, 赵媛媛, 彭浩南. 多巴胺基纳米材料在生物医药中的应用[J]. 化学进展, 2018, 30(8): 1228-1241.
[7] 谭晓晓, 李国帅, 王庆鹏, 王炳全, 李大成, 王鹏. 作为抗肿瘤药物的小分子四价铂[J]. 化学进展, 2018, 30(6): 831-846.
[8] 池滨, 侯三英, 刘广智, 廖世军*. 高性能高功率密度质子交换膜燃料电池膜电极[J]. 化学进展, 2018, 30(2/3): 243-251.
[9] 汤洁, 刘仁发, 戴志飞*. 多功能脂质体递药系统[J]. 化学进展, 2018, 30(11): 1669-1680.
[10] 孙悦文, 金素星, 王晓勇, 郭子建. 金属配合物在肿瘤化学免疫治疗中的应用前景[J]. 化学进展, 2018, 30(10): 1573-1583.
[11] 陈盼盼, 史兵兵*. 基于大环主体构筑的超分子载药体系[J]. 化学进展, 2017, 29(7): 720-739.
[12] 张凤香, 白赢*, 杨晓玲, 厉嘉云, 彭家建*. N-杂环卡宾铂配合物的合成及其在有机反应中的应用[J]. 化学进展, 2017, 29(4): 412-425.
[13] 龚兆翠, 尹超, 赵惠, 卢晓梅, 范曲立, 黄维. 光控纳米载体在药物释放中的应用[J]. 化学进展, 2016, 28(9): 1387-1396.
[14] 蒋革, 罗锋, 徐耀忠, 张晓辉. 近紫外光辅助4-硫脱氧胸苷抗癌作用的研究[J]. 化学进展, 2016, 28(8): 1224-1237.
[15] 郑小辉, 夏立新, 毛宗万. 基于核酸修饰新策略的抗肿瘤铂配合物设计[J]. 化学进展, 2016, 28(7): 1029-1038.